mRNA-based skin identification for forensic applications
International Journal of Legal Medicine, 2011
Authors
Journal
International Journal of Legal Medicine
Study Design
Addressed Question
Identification and specificity of mRNA markers for the identification of skin
Activity Context
Category
Specifications
Variables of Interest
Stringency of Control
Number of Individuals
15
Replicates per Individual and Condition
2-15
Nucleic Acid
Bodily Origin
Depositor & Contact
Depositor Characteristics
8 men, 7 women, 22-42 years
Criteria for Shedder Status
N/A
Previous Activities
before sampling skin: handwashing, 30 min of not touching often touched surfaces
Contact Scenario
sampling (within 1 hour)
Primary Substrate
Primary Substrate Type
body fluids (skin, blood, saliva, semen, vaginal fluids)
Primary Substrate Material
Deposit
regular presence
Delay
N/A
Secondary Substrate
Secondary Substrate Type
N/A
Secondary Substrate Material
N/A
Secondary Substrate Contact
N/A
Further Transfer
N/A
Sampling
Background DNA on Sampled Surface
Sampling Time
direct/delayed
Persistence
N/A
Sampling Method
skin, saliva: swabbing; blood: fingerprick, venipuncture; Semen, menstrual blood, vaginal secretions: as described previously
Sampling Area
skin samples: whole hand area
Laboratory Analysis
Extraction
blood: phenol-chloroform + Rneasy Plus mini Kit; saliva: Rneasy Plus Mini kit; skin: Rneasy Fibrous Tissue Mini kit; semen, menstrual blood and vaginal secretion: as described previously
DNA Quantification
RNA: NanoDrop ND-1000 spectrophotometer
Input for Profiling
5-11 µl total RNA for cDNA synthesis, 2µl of 5-fold diluted cDNA for RNA profiling
Profiling
RNA: qPCR of target candidate genes (CALML5, CDSN, DCD, DSC1, FLG, KRT1, KRT21, KRT9, KRT10, LOR, SCGB2A2) and reference genes (ACTB, B2M GAPDH, PP1B, UBC)
Reference Samples
N/A
Profile Interpretation and Mixture Analysis
N/A
RNA Data Interpretation
determination of Ct and dCt (-reference gene)
Results
DNA Quantity
N/A
Profile Quality
N/A
Parameter Used for Comparison
expression levels of mRNAs (Ct) in skin and different forensic body fluids, dCt
Summary of Results
high expression in skin samples together with over-expression in skin samples relative to all other relevant cell types tested determined for: CDSN, LOR, KRT9; most stable reference gene: ACTB; CDSN, LOR and KRT9 expression detected in most skin samples; substantial variation in dCt values between individuals (but not between left and right hand from one individual) - assumed reason: variation in amount of material deposited; dCt samples in skin significantly lower than in non-skin samples for all three markers; slightly increased skin mRNA markers in saliva and vaginal secretions; dCt threshold for skin vs non-skin samples: 2.7 (dCt<2.7 -> skin)
Raised Questions
incorporation of skin-specific mRNA markers into multiplex assays targeting all forensically relevant cell types for mixture determination
Cautionary Remarks
no precise guideline for the detection of skin described: dCt threshold? Detection of one or all skin-specific mRNA markers?; how to implement dCt threshold into mixture analysis?